INTRODUCTION
One of the distressing phases of lepromatous leprosy is the lepra reaction. Some unfortunate ones get these bouts repeatedly and some others are almost continuously in reaction. Though relief can be given with treat ment, it is temporary and repeated episodes of the reactionary phase progressively push the patients down hill. Lepromatous leprosy being a systemic disease M. Leprae is widely disseminated throughout the body. With such generalisation of the disease there is widespread infiltration of the skin, liver, testes, etc.
In such cases, clinically hypo-proteinemia and anaemia, are evident. Patients complain of pains and aches in the bones and joints, because during these reactions the adverse effect of leprosy on bones is at its worst (2) . They often comp)ain of testicular pain, general asthenia, and anorexia and their depressed mental state is obvious. In keeping with these signs and symptoms, the fo llowing abnormal findings are usually noted :
I. Loss of weight. 2. Reversed albumin : globulin ratio. 3. Increased Erythrocyte Sedimentation Rate (E.S.R.). 4 . Decreased Haemoglobin. 5 . Swelling of hands and fe et. 6. Osteoporotic changes.
Lepra reaction does not seem to be a specific uniform response to one causative agent but it seems to be a response to a large number of widely differing agents. The therapeutic problem becomes more complicated and difficult because the exact nature of lepra-reaction is not clearly under stood. Hence a clinician is continually hunting fo r better methods of relief and treatment. The p resent p a p er can be best described as a re p ort on such a hunt. Recently, several non-steroid compounds allied to testos terone e.g. *Oxymethalone, i.e. I i Beta HydroxY-2 hyd roximethylene-17 alpha-methylandrostan-3 and * I 9 nor-androstenolone phenyl propionate **have come in use. They have a very fa vourable anabolic action and their androgenic eff ects are not as prominent (4) . Therefore a wider application of these drugs even in fe males is possible. Pharmacologically and therapeutically they are fo und to be useful in conditions where there are manifestations of hypo-protei nemi a as reflected by reversal of albumin : globulin ratio, oedema, decrease in body weight, asthenia, and depression etc. In leprosy subjects in question such a picture is very common, and hence one is inclined to employ these drugs in such cases as the signs and symptoms in these patients dovetail nicely with the therapeutic effects of this medication. Anapolon and Dur abolin are also known to influence the calcium metabolism. This is an important therapeutic property as applied to leprosy, because it is known that derangement in blood calcium levels occurs with advanced disease ( I, 3). The eff ect of these drugs on calcium metabolism is of greater interest now, as glucocorticoids commonly used in the treatment of lepra reaction are known to induce osteoporosis (7).
M. Leprae is known to invade the liver. Consequently liver fu nctions are disturbed (6) . Salubrious effects of anti-diabetic sulphonamide com pounds on the liver fu nction have been reported (5). Therefore in view of involvement of liver in leprosy *** D-860-Tolbutamide was added to this therapeutic study.
MATERIALS AND METHOD
Six patients of leprosy of lepromatous type have been studied. These patients were almost constantly suffering fr om reactions fo r a period vary-. ing between 2 and 5 years . Their skin smears were highly positive fo r M. leprae and the histological picture of skin biopsis confirmed the lepro matous type. They had oedema of hands and fe et, which pitted on pressure. But this oedema was different fr om the one seen in Congestive Cardiac Failure which easily pits on pressure. All the patients were males. Their ages varied between 26 to 36 years. The general condition of these patients was poor. Two out of six cases were advanced cases and were bed-ridden (Case Nos. I & 2) ; two cases (Case No. 3 & 4) were of moderate type. Cases NO. 5 & 6 were not fa r advanced and severity of their disease was even less than Case NO. 3 and 4. Patients suffering fr om liver cirrhosis, cardiac and kidney diseases or diabetes were excluded. In all these patients Venereal Disease Research Laboratory test (V.D.R.L.) was negative and fa sting blood sugar levels were within normal limits. Renal fu nction tests done before therapeutic trials were within normal limits.
*Hereafter the trade names of the preparations *Anapolon and **Durabolin will be used respectively .
.. "Hereafter the trade name of Rastinon will be used.
METHODS
All the patients were inpatients and of a leprosy hospitalt. Case No. I was administered injection Durabolin only all along the course of the treatment. All the other five patients were given Anapolon fo r a period of first three months. Later they were put on injection Dura bolin during the rest of the treatment schedule.
The fo llowing drugs were used as and when required. Gluco-corticoids trivvalent antimony compounds, Vit. B. Complex, Vit. C, Iron, Glucose, calcium, either orally or parentarally. Such supportive treatment was fo und to be of not much use prior to the use of the drugs under trial. These patients were given high protein diet in the 'form of milk reinforced by milk powder and eggs, in addition to their routine hospital diet.
RESULTS
The results of these investigations are given in the accompanying tables. It is obvious fr om Table No. I that all the patients have put on weight. There was an improvement in general health . They had a sense of well being. Those that were bed-ridden became ambulant (Case No. I & 2) . However case No. I deteriorated during last three months. There is decrease in E.S.R. in all the cases except Case NO. 4. Haemoglobin percentage and red blood cell counts have improved in all the patients except Case NO· 3· The X-ray pictures of the Cases NO. 5 and 6 showed fa ir amount of re calcification and arrest of atrophic changes. No such changes were observed in other patients ( Table 2) . During the first three months of trials there was an impression that the fr equency of lepra reactions was reduced. But at the end of this study it was fo und that there was no significant reduction in the number of reactions or their severity. SUMMARY Anabolic agents (Anapolon, Durabolin) have been therapeutically tried along with Rastinon (oral anti-diabetic agent) in cases of lepromatous leprosy.
An over-all improvement in body weight, E.S.R. and Haemoglobin percentage have been observed. In two cases recalcification of bones and arrest of process of osteoporosis is noted. Evaluation of the individual drug is indicated.
